The FDA cautions that alerts from smartphone-connected diabetes devices may not be delivered or heard, potentially leading to serious health risks.
By
Lana Pine
| Published on February 5, 2025
2 min read
Credit: Adobe Stock/A_B_C
The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding diabetes devices, including continuous glucose monitors (CGMs) and insulin pumps, that rely on smartphones to deliver critical alerts.
Users can configure these settings through the app on their phone. However, in some cases these results are not being delivered or not being heard. Reports indicate that some users are not receiving or hearing these alerts due to software settings (such as enabling “do not disturb” and “focus mode” or entering “deep sleep” after a period of inactivity), hardware changes (when connecting to headphones or car audio), or operating system updates, which may contribute to severe health risks, including low blood sugar (hypoglycemia), high blood sugar (hyperglycemia), diabetic ketoacidosis and death.
The FDA offered some recommendations for patients using these applications:
The FDA is collaborating with diabetes-related device manufacturers to improve safety measures and ensure reliable alert delivery.